Specific mutations in GDF5 that result in a selective inactivation of the binding to BMPR1B are a cause of BDA2 [19], [20], similarly to dominant negative mutations in the GDF5 high-affinity receptor BMPR1B itself [17], [18]. The gene discussed is BMPR1B; the disease is brachydactyly type A2.